Viewing 0 reply threads
  • Author
    Posts
    • #13269

      Mylan has been granted rights to market in the U.K. TOBI Solution and TOBI Podhaler to treat P. aeruginosa lung infections in cystic fibrosis patients. Read more here.

      How do you feel about this news?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account